McKesson, Meditech named first ‘test EHRs’

The Centers for Medicare & Medicaid Services and the Office for the National Coordinator for Health IT announced that McKesson and Meditech are the first two official “test EHRs,” selected from among certified EHRs.

These test EHRs will play a role in helping eligible professionals, hospitals and critical access hospitals comply with the third transition of care objective measure under Stage 2 of Meaningful Use.

Under Stage 2, entities must demonstrate progress of their interoperable systems by either conducting one of more successful electronic exchanges of a summary of care document with a recipient who uses a different EHR system; or by conducting one or more successful tests with the CMS-designated test EHR during the reporting period.

Both companies, as well as athenahealth, participated in an ONC and National Institute for Standards & Technology pilot last fall to finalize testing procedures.

“We strongly encourage others in the EHR technology developer community to participate in the program to become a CMS-designated test EHR,” according to a joint-agency announcement.

More information on becoming a test EHR is here.

 


 


 



 

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.